<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Many of the spinocerebellar <z:hpo ids='HP_0001251'>ataxias</z:hpo> (SCAs) are caused by expansions of CAG trinucleotide repeats encoding abnormal stretches of polyglutamine </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e> or <z:e sem="disease" ids="C0024408" disease_type="Disease or Syndrome" abbrv="MJD|SCA3">Machado-Joseph disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e>) is the commonest dominant inherited <z:hpo ids='HP_0001251'>ataxia</z:hpo> disease, with pathological phenotypes apparent with a CAG triplet repeat length of 61-84 </plain></SENT>
<SENT sid="2" pm="."><plain>In this study a mouse model of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e> has been examined which was produced using a human yeast artificial chromosome containing the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e> gene with a CAG triplet expansion of 84 repeats </plain></SENT>
<SENT sid="3" pm="."><plain>These mice have previously been shown to possess a mild progressive cerebellar deficit </plain></SENT>
<SENT sid="4" pm="."><plain>NMR-based metabolomics/metabonomics in conjunction with multivariate pattern recognition identified a number of metabolic perturbations in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e> mice </plain></SENT>
<SENT sid="5" pm="."><plain>These changes included a consistent increase in glutamine concentration in tissue extracts of the cerebellum and cerebrum and spectra obtained from intact tissue using magic angle <z:mp ids='MP_0001411'>spinning</z:mp> (1)H-NMR spectroscopy </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, these profiles demonstrated <z:mp ids='MP_0005266'>metabolic abnormalities</z:mp> were present in the cerebrum, a region not previously implicated in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>As well as an increase in glutamine both brain regions demonstrated decreases in <z:chebi fb="3" ids="16865">GABA</z:chebi>, <z:chebi fb="3" ids="15354">choline</z:chebi>, <z:chebi fb="0" ids="36700">phosphocholine</z:chebi> and <z:chebi fb="4" ids="24996">lactate</z:chebi> (representing the summation of <z:chebi fb="4" ids="24996">lactate</z:chebi> in vivo, and postmortem glycolysis of <z:chebi fb="105" ids="17234">glucose</z:chebi> and <z:chebi fb="15" ids="28087">glycogen</z:chebi>) </plain></SENT>
<SENT sid="8" pm="."><plain>The metabolic changes are discussed in terms of the formation of <z:mp ids='MP_0004191'>neuronal intranuclear inclusions</z:mp> associated with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>This study suggests high-resolution (1)H-NMR spectroscopy coupled with pattern recognition may provide a rapid method for assessing the phenotype of animal models of human disease </plain></SENT>
</text></document>